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Essentials
• Why venous thrombosis is more prevalent in chronic kidney disease is unclear.
• We investigated whether renal and vascular function are associated with hypercoagulability.
• Coagulation factors showed a procoagulant shift with impaired renal and vascular function.
• This suggests that renal and vascular function play a role in the etiology of thrombosis.
Summary. Background: Impaired renal and vascular function have been associated with venous thrombosis, but the mechanism is unclear. Objectives: We investigated whether estimated glomerular filtration rate (eGFR), urinary albumin-creatinine ratio (UACR), and pulse wave velocity (PWV) are associated with a procoagulant state. Methods: In this cross-sectional analysis of the NEO Study, eGFR, UACR, fibrinogen, and coagulation factors (F)VIII, FIX and FXI were determined in all participants (n = 6536), and PWV was assessed in a random subset (n = 2433). eGFR, UACR and PWV were analyzed continuously and per percentile: per six categories for eGFR (> 50 th [reference] to < 1st) and UACR (< 50
[reference] to > 99th), and per four categories (< 50
[reference] to > 95th percentile) for PWV. Linear regression was used and adjusted for age, sex, total body fat, smoking, education, ethnicity, total cholesterol, C-reactive protein (CRP) and vitamin K antagonists use (FIX). Results: Mean age was 55.6 years, mean eGFR 86.0 (12SD) mL 1.73 m À ² and median UACR 0.4 mg mmol À1 (25th, 75th percentile; 0.3, 0.7). All coagulation factors showed a procoagulant shift with lower renal function and albuminuria. For example, FVIII was 22 IU dL À1 (95% CI, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] higher in the eGFR < 1st percentile compared with the > 50th percentile, and FVIII was 12 IU dL
À1
(95% CI, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] higher in the UACR > 99th percentile compared with the < 50th percentile. PWV was positively associated with coagulation factors FIX and FXI in continuous analysis; per m/s difference in PWV, FIX was 2.0 IU dL À1 (95% CI, 0.70-3.2) higher. Conclusions:
Introduction
Venous thrombosis plays a major role in the morbidity and mortality of patients with advanced renal disease [1] . Previous studies have shown that impaired renal function and the presence of microalbuminuria in patients with chronic kidney disease (CKD) are associated with an increased risk of venous thrombosis [2, 3] . To illustrate, individuals with an estimated glomerular filtration rate (eGFR) < 60 mL min À1 1.73 m À ² have a 2-3-fold increased risk of venous thrombosis compared with individuals with normal renal function [4, 5] . Moreover, impaired renal function is associated with higher levels of coagulation factors, including fibrinogen, factors (F) VII, FVIII, FIX and FXI, and von Willebrand factor [6] . This supports the hypothesis that the increased risk of venous thrombosis in CKD could be induced by elevated coagulation factor levels due to generalized endothelial damage [6] . Previous studies have focused on either the increased risk of venous thrombosis or the presence of CKD in relation to coagulation factors [5] . However, it remains unclear whether impaired vascular function is associated with higher levels of coagulation factors in the general population. Moreover, the few studies thus far evaluating associations between renal function, albuminuria and coagulation did not account for inflammation as a potential confounder [7, 8] . Atherosclerosis measured by intimamedia thickness has been suggested as a possible risk factor for VTE [9] , and atherosclerosis has been associated with a procoagulant state [10] . Arterial stiffness assessed by pulse wave velocity (PWV) is a functional and more robust marker for early atherosclerosis than intima-media thickness [11] , [12] and has been linked with endothelial shear stress [13] . Moreover, recent insights showed that arterial stiffness is regulated by hemodynamic and mechanosensitive properties of endothelial cells, reflecting systemic vascular function [14, 15] . Thus far, the association between vascular function (i.e. endothelial dysfunction and arterial stiffness) and hemostasis in the general population remains elusive.
We hypothesize that impaired renal function and impaired vascular function are associated with hypercoagulability, evidenced by a procoagulant shift in coagulation factors that could ultimately lead to venous thrombosis, (Fig. 1 ).
Material and methods

Study population and study design
The Netherlands Epidemiology of Obesity (NEO) study is a population-based, prospective cohort study in 6671 individuals aged 45-65 years [16] . Recruitment of participants started in September 2008 and was completed at the end of September 2012. Men and women living in the greater area of Leiden (in the west of the Netherlands) were invited by letters sent by GPs and municipalities and by local advertisements. They were invited to respond if they were aged between 45 and 65 years and had a selfreported body mass index (BMI) of 27 kg m À2 or higher.
In addition, all inhabitants aged between 45 and 65 years from one municipality (Leiderdorp) were invited to participate irrespective of their BMI, allowing for a reference distribution of BMI. Exclusion criteria were missing data on eGFR, urinary albumin excretion, fibrinogen or FVIII, FIX or FXI. All participants were screened for potential contraindications for magnetic resonance imaging (MRI) (metallic devices, claustrophobia or a body circumference of ≥ 1.70 m) at the NEO study center, and approximately 30% of the participants eligible for MR imaging were randomly selected to undergo MRI imaging. Participants with missing PWV measurements due to technical failures were excluded from further analysis. The Medical Ethical Committee of the Leiden University Medical Center (LUMC) approved the design of the study and all participants gave their written informed consent.
Data collection
Participants were invited to a baseline visit at the NEO study center of the LUMC after an overnight fast. Prior to this study visit, participants collected their urine over 24 h and completed a general questionnaire at home to report demographic, lifestyle and clinical information. The participants were asked to bring all medication they were using to the study visit. At the baseline visit all participants underwent physical examination, including anthropometry and blood pressure. Height was measured using a calibrated tape measure and bodyweight and percentage of total body fat (TBF) were measured using the Tanita bio impedance balance (TBF-310, Tanita International Division, UK). Weight in kilograms was divided by height in meters squared to calculate BMI.
Serum measurements Fasting blood samples were drawn from the antecubal vein after the participant had rested for 5 min. Subsequently, fasting glucose, triglyceride, lowand high-density lipoprotein concentrations, C-reactive protein (CRP) and serum creatinine were measured with standard methods in the central clinical chemistry laboratory of the LUMC [16] . Serum creatinine (mg dL À1 ) was used to calculate estimated glomerular filtration rate (eGFR) using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula [17] .
Urine measurements Urinary albumin was measured in an early-morning single urine void using an immunoturbidimetric assay and creatinine using a Jaffe kinetic compensated method between 1 September 2008 and 30 November 2010 and an enzymatic assay (IDMS calibrated against SRM 967) from 1 December 2010 until the end of the inclusion period. Because urinary creatinine concentrations are not affected by pseudochromogens they are exchangeable using either a Jaffe or an enzymatic method.
Plasma measurements Blood samples for coagulation factor measurements were drawn into tubes containing 0.106 M trisodium citrate (Sarstedt, N€ umbrecht, Germany). Plasma was obtained by centrifugation at 2500 9 g for 10 min at room temperature and stored in aliquots at À80°C until testing. ) and albuminuria (also referred to as macroalbuminuria or severely increased albuminuria) as UACR > 30 mg mmol À1 [18] .
Assessment of arterial stiffness For the assessment of arterial stiffness, pulse wave velocity (PWV) was determined on a 1.5 Tesla (T) whole-body magnetic resonance imaging (MRI) scanner (Gyroscan ACS/NT15, Philips, Best, the Netherlands) using multi-slice, twoone-directional in-plane velocity-encoded MRI. PWV was calculated by the ratio of the distance along the aortic center line (Dx) and the transit-time of the propagating systolic pulse wave between two measurement sites (Dt) (proximal aorta and distal aorta summed) [19] . An overview of the assessment of PWV is given in Fig. 2 .
Statistical Analysis
In the NEO study individuals with a BMI of 27 kg m À2 or higher were oversampled. First, inhabitants of Leiden and its surrounding area between 45 and 65 years of age and with a self-reported BMI of 27 kg m À ² or higher were invited to participate in the NEO study. In addition, we included a reference population. To that extent, all inhabitants between 45 and 65 years living in one municipality, Leiderdorp, were asked to participate irrespective of their BMI. This resulted in an additional sample of 1671 participants with a BMI distribution that was similar to the BMI distribution of the general Dutch population [20] . If inference is made on the general population, the overrepresentation of overweight and obese participants in the NEO study may introduce bias because of the skewed BMI distribution in the NEO population. Weighting towards the BMI distribution of the general population may solve this problem [21] . Using the BMI distribution of the reference population, we calculated weight factors for the NEO population, resulting in a higher weight factor for participants with a lower BMI (Table S3) . Use of sampling weights yields results that apply to a population-based study without oversampling of individuals with a high BMI [22] . Consequently, the results apply to a population-based study without oversampling of individuals with a high BMI. Figure S1 shows that the use of the weight factors results in a BMI distribution that is similar to that of the general population.
Baseline characteristics of the weighted study population are expressed as mean (SD), median (25th and 75th percentile) or percentage. Determinants were eGFR (CKD-EPI), urinary albumin-creatinine ratio (UACR) and pulse wave velocity (PWV). Outcome variables were fibrinogen, FVIII, FIX and FXI. UACR was log-2 transformed because this variable has a right-skewed distribution. Both renal function and albuminuria were grouped into six categories based on percentiles (> 50th [reference], 10th to 50th, 5th to 10th, 2.5th to 5th, 1st to 2.5th and < 1st percentile for eGFR; and < 50th [reference], 50th to 90th, 90th to 95th, 95th to 97.5th, 97.5th to 99th, and > 99th percentile for albuminuria). Because of the smaller sample size, pulse wave velocity was grouped into four instead of six categories based on percentiles (< 50th [reference] , 50th to 90th, 90th to 95th, > 95th percentile). The use of percentile groups allows for the evaluation of wide ranges of values, particularly for abnormal levels. We calculated age-and sex-adjusted mean differences with 95% confidence intervals (CIs) in levels of hemostatic factors for the defined categories, compared with the reference using linear regression. Multiple linear regression was used to calculate the difference with 95% CIs in levels of hemostatic factors for every 10 mL min À1 1.73 m À ² change in eGFR, per 2-fold change in albuminuria, and per ml/min change in PWV.
Crude analyses were adjusted for age, sex, smoking (current, former, never), total body fat, CRP, total cholesterol, use of vitamin K antagonists (for FIX only), ethnicity and education. In order to correct for dyslipidemia we only added total cholesterol to the regression analysis, and not other measures of dyslipidemia, in order to diminish the chance of an overfit statistical model. Additionally, we performed an analysis for clinical cut-off points for renal function (mildly to moderately reduced renal function [eGFR 45-90 mL min < 45 mL min À1 1.73 m À ²]) and albuminuria (UACR > 3 mg mmol À1 ). Because gender and age-specific cut-off points for vascular dysfunction based on PWV measured by MRI are yet to be defined, we investigated associations of PWV with the clotting factors over the whole range of PWV as a continuous variable and in percentiles. First-degree linear spline modelling was used for exploring non-linear associations between renal function, vascular function and coagulation factors. Piecewise linear function was used, meaning that the adjusted regression models were composed of linear segments based on equally spaced knots (quintiles) [23] . Analyses were performed using STATA (Statacorp, College Station, Texas, USA, version 12.0).
Results
Baseline characteristics
The total NEO study population consisted of 6671 participants. After consecutive exclusion of participants with missing data on renal function (n = 50), albuminuria (n = 27), coagulation factors (n = 57) or fibrinogen (n = 1), the final study population consisted of 6536 participants with a mean (SD) age of 55. Microalbuminuria was present in 2.0% and albuminuria in 0.4% of the participants; 4% of the participants had diabetes. ACE inhibitors or angiotensin-II antagonists were used by 14% of the participants. Baseline characteristics of the included study population are presented in Table 1 . Approximately 30% of the participants who were eligible for additional MRI were randomly selected to undergo PWV measurement (n = 2,576). Participants with missing PWV measurements due to technical failures (n = 143) were excluded from further analysis. The complete subgroup of participants with available PWV measurements consisted of 2433 individuals, and was not statistically different from participants without PWV measurements (data not shown).
Associations of Determinants of Vascular Function with Coagulation Factors
Adjusted mean differences of renal function, albuminuria and arterial stiffness percentiles, and coagulant factors are provided in Tables 2-5 . Crude mean differences and linear regression coefficients are provided in the online supplementary material (Table S1 and S2).
Compared with participants with an eGFR > 50th percentile, the adjusted mean coagulation factor levels in participants with an eGFR < 1st percentile were 33 (19) eGFR, estimated glomerular filtration rate according to the CKD-EPI formula; UAE, urinary albumin excretion; UACR, urinary albumin-creatinine ratio. Results were weighted toward the body mass index (BMI) distribution of the general population (n = 6536).
Results are expressed as %, means (standard deviation) or medians (25th, 75th percentile). *Diabetes; raised fasting plasma glucose concentrations (≥ 5.56 mmol LÀ1) or on drug treatment to lower glucose concentrations. †Cardiovascular disease; myocardial infarction, angia pectoris, congestive heart failure. ‡Thromboembolic event; pulmonary embolism, deep venous thrombosis. §Pulse wave velocity; assessed in n = 2433.
percentiles. Participants with moderately to severely decreased kidney function (eGFR <45 mL min Results were weighted toward the body mass index distribution of the general population (N = 6536). Corresponding linear regression coefficients and 95% confidence intervals. *Adjusted for sex, age, smoking, total body fat, C-reactive protein, total cholesterol, ethnicity and education. †Vitamin K antagonist users were excluded from the analysis. eGFR, estimated glomerular filtration rate according to the CKD-EPI formula Corresponding linear regression coefficients and 95% confidence intervals. Results were weighted toward the body mass index distribution of the general population (n = 6536). *Adjusted for sex, age, smoking, total body fat, C-reactive protein, total cholesterol, ethnicity and education. †Vitamin K antagonist users were excluded from the analysis. UACR, urinary albumin-creatinine ratio. Corresponding linear regression coefficients and 95% confidence intervals. Results were weighted toward the body mass index distribution of the general population (n = 2433). *Adjusted for sex, age, smoking, total body fat, C-reactive protein, total cholesterol, ethnicity and education. †Vitamin K antagonist users were excluded from the analysis. PWV, pulse wave velocity.
IU dL À1 for FIX and 4 (95% CI, 0 to 9) IU dL À1 for FXI compared with participants with an UACR < 50th percentile. When using clinical cut-off points to categorize albuminuria instead of percentiles, participants with microand/or macroalbuminuria (UACR > 3 mg mmol
À1
) had, as compared with participants with normal-range albuminuria (UACR < 3 mg mmol À1 ) ( For arterial stiffness the adjusted mean coagulation factor levels of participants with PWV > 95th percentile were 11.4 (95% CI, À2.6 to 25.4) mg dL À1 for fibrinogen, À1
(95% CI, À9 to 8) IU dL À1 for FVIII, 7 (95% CI, À1 to 15) for FIX and 4 (95% CI, À2 to 10) for FXI compared with participants with PWV < 50th percentile. An overview of the adjusted mean factor levels of the < 1st percentile eGFR, > 99th percentile UACR and > 95th percentile PWV compared with the reference percentile category (> 50th percentile for eGFR and < 50th percentile for UACR and PWV) is visualized in Fig. 3 . Spline models showing the association between eGFR, UACR, PWV and coagulation factors fibrinogen, FVIII, FIX and FXI, suggest an inverse relationship between renal function and coagulation factors, and a positive relationship between vascular function and coagulation factors (except for fibrinogen). Results of spline models are visualized in Fig. S2 .
Discussion
In this large population-based cross-sectional study, coagulation factors showed a procoagulant shift with all three determinants of lower vascular function, and the found associations were most pronounced for FVIII (for eGFR and UACR) and FIX (for PWV).
We found that the adjusted mean coagulation factor levels for participants with an eGFR < 60 mL min ), while controlling for various confounding factors including CRP. These findings are supported by results based on linear spline models, except for the relationship between PWV and fibrinogen, for which we have no biological explanation. Our study adds novel information to the previous population-based multi-ethnic MESA study that observed that a decline in renal function was associated with both coagulation factors (fibrinogen and FVIII) and an increase in inflammatory markers (such as CRP and IL-6) in participants without cardiovascular disease or chronic kidney disease [7, 24] . However, previous observations were limited by the use of coagulation factors that are also acute Results were weighted toward the BMI distribution of the general population (n = 6536). Corresponding linear regression coefficients and 95% confidence intervals. *Adjusted for sex, age, smoking, total body fat, C-reactive protein, total cholesterol, ethnicity and education. †Vitamin K antagonist users were excluded from the analysis. eGFR, estimated glomerular filtration rate according to the CKD-EPI formula; UACR, urinary albumin-creatinine ratio. Procoagulant factor >95th percentile PWV (>9.14 m s -1 ) Fig. 3 . Overview of the adjusted mean factor levels of the < 1st percentile estimated glomerular filtration rate (eGFR), > 99th percentile urinary albumin-creatinine (UACR) and > 95th percentile pulse wave velocity (PWV) compared with the reference percentile category. Results were weighted toward the body mass index (BMI) distribution of the general population (N = 6536). Adjusted for sex, age, smoking, total body fat, C-reactive protein (CRP), total cholesterol, ethnicity and education. Corresponding linear regression coefficients and 95% confidence intervals. The reference percentile category for eGFR was > 50th percentile for eGFR, < 50th percentile for UACR and PWV. Vitamin K antagonist users were excluded from the analysis of factor IX.
phase reactant proteins, meaning that previous findings could have been solely a reflection of the association of endothelial dysfunction with inflammation. In the context of CKD, markers of endothelial dysfunction have been associated with a hypercoagulable state and raised levels of FVIII and von Willebrand factor, with an increased thrombo-embolic risk [6, 25] . This is supported by the observed normalization of endothelial dysfunction and hypercoagulability after renal transplantation [26, 27] , suggesting a causal relationship between renal vascular function and hypercoagulability [28] . We observed that higher levels of albuminuria are associated with higher levels of coagulation factors. For the > 99th UACR percentile (> 6.21 mg mmol À1 ) these findings were most pronounced for FVIII and fibrinogen. FVIII is of particular interest because it is synthesized by vascular, glomerular and tubular endothelium, as well as the sinusoidal cells of the liver. FVIII could therefore be considered both as a marker of endothelial dysfunction and a risk factor for venous thrombosis [25] . The found link between higher levels of albuminuria and a procoagulant state in this study might be explained by endothelial regulation of vascular homeostasis, which could become dysfunctional due to sustained inflammatory endothelial activation [29] . Two other studies evaluating the association between UACR and venous thromboembolism, however, did not observe such an association [30, 31] . In the present study, the differences in adjusted mean coagulation factor levels for the highest/lowest percentile compared with the reference category were also most pronounced for eGFR, rather than for albuminuria or arterial stiffness.
In the current study we found a positive association between increased arterial stiffness and higher levels of FIX and FXI in continuous analysis; however, this association was not convincingly present when the analyses were based on percentile cut-offs of arterial stiffness. Arterial stiffness is a reflection of the elastic properties of a vessel (i.e. compliance and ability to contract and dilate), which are mainly determined by the intima-media and can respond to mechanical changes through the production of vasoactive molecules, extracellular matrix and extracellular matrix-degrading proteases [15] . Previous basic science studies have shown that mechanical injury to vasculature can result in an increased procoagulant state [32; however, further studies are needed to verify whether a true association exists between arterial stiffness and the coagulation system. Strengths of our study are the large sample size with extensive phenotyping, including data on four different coagulation factors and data on three different measures of vascular function. Both albuminuria and arterial stiffness can be considered to reflect systemic vascular injury; albuminuria may potentially serve as a surrogate marker of systemic endothelial dysfunction [33] , and arterial stiffness as a marker of intima-medial calcification [11, 34] .
Arterial stiffness was assessed in a large random subgroup using MRI, which is highly superior to conventional tonometry [19] and has not been studied in relation to coagulation thus far.
This study also has a number of limitations that need to be considered. The observed associations appeared to be strongest in individuals with the lowest renal and vascular function. It must be noted that these individuals represented only 1% of the total population, because this is a population-based analysis without any prior selection criteria for chronic kidney disease. Therefore, our findings are representative for the general population rather than CKD patients. The results from the spline models also suggest an inverse relation between renal function and increased levels of procoagulant factors. Although our results are based on a population-based study, we cannot completely exclude the influence of other potentially clinically relevant conditions that would affect renal and vascular function in relation to coagulation factor levels.
Another limitation was the use of estimated GFR rather than (invasive) reference standard exogenous clearance measurements. Although the CKD-EPI formula has proven to be more accurate and precise than the older MDRD formula, it has not been validated above 90 mL min À1 1.73 m À ² [35] . Furthermore, in the present study overall markers of hypercoagulability or natural coagulation inhibitors such as D-dimer and antithrombin were unfortunately not measured and could not be taken into account in the analyses.
Our findings support the hypothesis that vascular function is a marker of hypercoagulability; however, the cross-sectional observational nature of our study precludes a causal interpretation. The exact mechanism explaining why CKD is associated with an increased risk of venous thrombosis remains unclear. Recently, potential novel pathways for the regulation of hemostasis and thrombosis in kidney disease have been described, suggesting that a subclinical inflammatory state initiates glomerular injury via altered expression of coagulation factors, rather than impaired renal function or vascular damage initiating procoagulant changes [28] . This has been supported by various laboratory findings and preclinical studies showing that renal cell-specific expression and activity of coagulation proteases, and their associated regulators and receptors, tend to alter during renal disease processes [28] . Future analysis with repeated measurements could contribute to the assessment of the direction of the observed associations between vascular function and coagulation factors.
In summary, in this middle-aged sample of the general population impaired renal and vascular function (i.e. albuminuria and arterial stiffness) was associated with higher levels of coagulation factors. These findings support the hypothesis that impaired renal and vascular function plays a role in the etiology of venous thrombosis.
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